Gait Improvement Following CSF Tap Test in NPH Patients With and Without Striatal Dopaminergic Deficit: A Preliminary Study.

IF 3.2 Q3 CLINICAL NEUROLOGY
Neurology. Clinical practice Pub Date : 2025-12-01 Epub Date: 2025-09-22 DOI:10.1212/CPJ.0000000000200549
Minju Kim, Young Ho Park, Yoo Sung Song, Kyunghun Kang, Ki-Su Park, Shin Young Jeong, Sang-Woo Lee, Eunjeong Ji, SangYun Kim, Etsuro Mori
{"title":"Gait Improvement Following CSF Tap Test in NPH Patients With and Without Striatal Dopaminergic Deficit: A Preliminary Study.","authors":"Minju Kim, Young Ho Park, Yoo Sung Song, Kyunghun Kang, Ki-Su Park, Shin Young Jeong, Sang-Woo Lee, Eunjeong Ji, SangYun Kim, Etsuro Mori","doi":"10.1212/CPJ.0000000000200549","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Recent studies have highlighted the occurrence of reduced striatal signal intensity on dopamine transporter (DAT) scans in patients with idiopathic normal pressure hydrocephalus (iNPH). The aim of our study was to investigate whether the extent of symptom improvement after a CSF tap test (TT) differs between iNPH patients with reduced striatal DAT uptake and those with normal uptake.</p><p><strong>Methods: </strong>We conducted gait analysis on 44 patients with iNPH who underwent DAT scans at Seoul National University Bundang Hospital (SNUBH) and Kyungpook National University Chilgok Hospital (KNUCH) both before and after a CSF TT. A positive response to the TT was defined as an improvement in walking speed of 10% or greater compared with baseline. We compared TT response rates between iNPH patients with and without striatal dopaminergic deficit using logistic regression models, with the medical institution (SNUBH, KNUCH) as a stratification variable.</p><p><strong>Results: </strong>Among 36 patients without striatal dopaminergic deficit, 22 patients (61.11%) exhibited a response after the TT, whereas among 8 patients with striatal dopaminergic deficit, 5 patients (62.5%) exhibited a response after the TT. The response rate after TT was not significantly different between the iNPH patients with and without striatal dopaminergic deficit (odds ratio 0.46; <i>p</i> value = 0.4048).</p><p><strong>Discussion: </strong>Our findings suggest that gait improvement after a CSF TT in patients with iNPH remains consistent regardless of the presence or absence of reduced striatal DAT uptake. Further research involving a larger cohort is necessary to validate these observations.</p>","PeriodicalId":19136,"journal":{"name":"Neurology. Clinical practice","volume":"15 6","pages":"e200549"},"PeriodicalIF":3.2000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12456307/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology. Clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1212/CPJ.0000000000200549","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Recent studies have highlighted the occurrence of reduced striatal signal intensity on dopamine transporter (DAT) scans in patients with idiopathic normal pressure hydrocephalus (iNPH). The aim of our study was to investigate whether the extent of symptom improvement after a CSF tap test (TT) differs between iNPH patients with reduced striatal DAT uptake and those with normal uptake.

Methods: We conducted gait analysis on 44 patients with iNPH who underwent DAT scans at Seoul National University Bundang Hospital (SNUBH) and Kyungpook National University Chilgok Hospital (KNUCH) both before and after a CSF TT. A positive response to the TT was defined as an improvement in walking speed of 10% or greater compared with baseline. We compared TT response rates between iNPH patients with and without striatal dopaminergic deficit using logistic regression models, with the medical institution (SNUBH, KNUCH) as a stratification variable.

Results: Among 36 patients without striatal dopaminergic deficit, 22 patients (61.11%) exhibited a response after the TT, whereas among 8 patients with striatal dopaminergic deficit, 5 patients (62.5%) exhibited a response after the TT. The response rate after TT was not significantly different between the iNPH patients with and without striatal dopaminergic deficit (odds ratio 0.46; p value = 0.4048).

Discussion: Our findings suggest that gait improvement after a CSF TT in patients with iNPH remains consistent regardless of the presence or absence of reduced striatal DAT uptake. Further research involving a larger cohort is necessary to validate these observations.

有纹状体多巴胺能缺陷和无纹状体多巴胺能缺陷的NPH患者脑脊液抽头试验后步态改善:初步研究。
背景和目的:最近的研究强调了特发性常压脑积水(iNPH)患者多巴胺转运体(DAT)扫描纹状体信号强度降低的发生。我们研究的目的是调查纹状体数据摄取减少和正常摄取的iNPH患者在脑脊液抽头试验(TT)后症状改善的程度是否不同。方法:我们对在首尔国立大学盆唐医院(SNUBH)和庆北国立大学漆谷医院(KNUCH)接受脑脊液TT前后进行数据扫描的44例iNPH患者进行了步态分析。对TT的积极反应被定义为步行速度比基线提高10%或更高。我们使用logistic回归模型,以医疗机构(SNUBH, KNUCH)作为分层变量,比较了纹状体多巴胺能缺陷和非纹状体多巴胺能缺陷的iNPH患者的TT反应率。结果:36例无纹状体多巴胺能缺陷的患者中,22例(61.11%)在TT后出现反应,8例纹状体多巴胺能缺陷的患者中,5例(62.5%)在TT后出现反应。纹状体多巴胺能缺陷与非纹状体多巴胺能缺陷的iNPH患者TT后的有效率差异无统计学意义(优势比0.46;p值= 0.4048)。讨论:我们的研究结果表明,无论纹状体数据摄取是否减少,iNPH患者脑脊液TT后的步态改善都是一致的。为了验证这些观察结果,有必要进行更大规模的进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurology. Clinical practice
Neurology. Clinical practice CLINICAL NEUROLOGY-
CiteScore
4.00
自引率
0.00%
发文量
77
期刊介绍: Neurology® Genetics is an online open access journal publishing peer-reviewed reports in the field of neurogenetics. The journal publishes original articles in all areas of neurogenetics including rare and common genetic variations, genotype-phenotype correlations, outlier phenotypes as a result of mutations in known disease genes, and genetic variations with a putative link to diseases. Articles include studies reporting on genetic disease risk, pharmacogenomics, and results of gene-based clinical trials (viral, ASO, etc.). Genetically engineered model systems are not a primary focus of Neurology® Genetics, but studies using model systems for treatment trials, including well-powered studies reporting negative results, are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信